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Abstract 
 
Activation of the trigeminal system plays an important role in the pathomechanism of 
headaches. A better understanding of trigeminal pain processing is expected to provide 
information helping to unravel the background of these diseases. ATP, a key modulator of 
nociceptive processing, acts on ligand-gated P2X receptors. Antagonists of the P2X7 
receptors, such as Brilliant Blue G (BBG), have proved effective in several models of pain. 
We have investigated the effects of BBG after electrical stimulation of the trigeminal ganglion 
and in the orofacial formalin test in the rat. The right trigeminal ganglion of male rats was 
stimulated either with 5 Hz, 0.5 mA pulses for 5 min (mild procedure) or with 10 Hz, 0.5 mA 
pulses for 30 min (robust procedure), preceded by 50 mg/kg i.v. BBG. The animals were 
processed for c-Fos and calcitonin gene-related peptide (CGRP) immunohistochemistry. In 
the orofacial formalin test, 50 µL of 1.5% formalin was injected into the right whisker pad of 
awake rats, following the pre-treatment with BBG. Behaviour was monitored for 45 min, and 
c-Fos and CGRP immunohistochemistry was performed. BBG attenuated the increase in c-
Fos-positive cells in the caudal trigeminal nucleus (TNC) after robust stimulation, but not 
after mild stimulation. No alterations in CGRP levels were found with either methodology. 
BBG did not mitigate either the behaviour or the increase in c-Fos-positive cells in the TNC 
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during the orofacial formalin test. These results indicate that P2X7 receptors may have a role 
in the modulation of nociception in the trigeminal system. 
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Introduction 
 
Primary headaches are very common, but underdiagnosed and undertreated neurological 
conditions. Even following the correct diagnosis, the available therapeutic options often do 
not provide complete resolution of the pain, and recurrence of the headache after treatment is 
also a common complaint. Research is therefore currently focused on gaining an 
understanding of the causes of different headache disorders and developing new therapeutic 
options.  
A common mechanism in primary headaches involves activation and sensitization of the 
trigeminal system, but the exact mechanism of these phenomena remains to be discovered 
(Tajti et al. 2011). 
Recent results suggest that the purine molecule ATP has an important role in the regulation of 
nociceptive transmission (Burnstock 2013). Molecules targeting the specific receptors (Rs) for 
ATP (P2X and P2Y-Rs) have been proven to be effective in modulating different pain 
conditions, e.g. neuropathic and inflammatory pain (Ando et al. 2010). Among the ligand-
gated P2X-Rs the P2X7 receptor (P2X7-R) has been intensively studied in different pain 
states. The P2X7-R is a non-selective cation channel, unique among the P2X-Rs by virtue of 
its long C terminal domain, and its ability to open a pore permeable to molecules up to 900 Da 
(Surprenant et al. 1996). Experiments with knock-out mice have revealed that absence of the 
P2X7-R leads to the disappearance of mechanical and thermal hypersensitivity in models of 
neuropathic and inflammatory pain, whereas normal nociceptive processing is retained 
(Chessell et al. 2005). P2X7-R antagonists have been examined in similar models, and the 
results underline the importance of the P2X7-R in chronic pain conditions (Honore et al. 
2006; McGaraughty et al. 2007). Results from an acute inflammatory pain model suggest that 
the P2X7-R may participate in the development of central sensitization (Itoh et al. 2011), a 
common feature in the trigeminal system during migraine attacks manifested by the presence 
of allodynia (Burstein et al. 2000). 
However, little information is available as concerns the role of P2X7-Rs in the trigeminal 
system. In a model of orofacial pain, the chronic constriction injury model, inhibition of the 
P2X7-R led to a decrease in tactile allodynia through a p38 MAPK-dependent mechanism (Ito 
et al. 2013). Gölöncsér and Sperlágh recently reported that blockade of P2X7-Rs in mice by 
Brilliant Blue G (BBG) (a selective, non-competitive P2X7-R antagonist, with good blood-
brain barrier permeability (Jiang et al. 2000)) reduced thermal hyperalgesia after systemic 
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nitroglycerin administration (Goloncser and Sperlagh 2014). These results lend support to the 
theory that P2X7-Rs may play a crucial part in the development of headache disorders. 
Calcitonin gene-related peptide (CGRP) has an essential role in trigeminal nociceptive 
processing. CGRP infusion causes migraine-like headache in migraineurs (Hansen et al. 2010; 
Lassen et al. 2002), and the levels of CGRP are higher in migraine patients than in healthy 
controls (Friberg et al. 1994).  
Electrical stimulation of the trigeminal ganglion, an animal model of trigeminal activation, 
causes plasma protein extravasation (Markowitz et al. 1987), which can be attenuated by 
drugs effective in migraine therapy (Limmroth et al. 2001). The stimulation results in 
alterations in the dura mater (Knyihar-Csillik et al. 1995), in the trigeminal ganglion and in 
the caudal part of the spinal trigeminal nucleus (TNC) (Knyihar-Csillik et al. 1998). In 
previous investigations, various stimulation frequencies, intensities and durations were 
applied. Results related to peptide release and c-Fos expression in the TNC after the 
procedure suggest that both higher frequency and higher intensity lead to an increased 
stimulation of the trigeminal ganglion cells (Samsam et al. 1999; Takemura et al. 2000). 
Diverse periods of stimulation caused different morphological alterations in the CGRP-
immunoreactive nerve terminals of the dura mater, suggesting the release of CGRP after 
prolonged stimulation (Knyihar-Csillik et al. 1995). Based on these previous results we 
decided to perform the electrical stimulation in two different setups: a mild and a robust one. 
Formalin applied to the whisker pad of rats (another model of trigeminal activation) causes a 
biphasic behavioural effect, the first phase being caused by the direct activation of Aδ and C 
fibres, while the second phase reflects the process of inflammation (Porro and Cavazzuti 
1993). Activation of the trigeminal system has been demonstrated by c-Fos 
immunohistochemistry to be present at the level of the TNC after the injection of formalin 
(Wang et al. 1994). Both phenomena are suitable for assessments of the influence of 
substances on inflammation. 
The aim of the present study was to examine the effects of a P2X7-R antagonist, BBG, in the 
electrical stimulation and orofacial formalin models of acute trigeminal activation.  
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Materials and Methods 
 
Ethical approval 
 
The procedures used in this study followed the guidelines of the 8th Edition of the Guide for 
the Care and Use of Laboratory Animals and the Use of Animals in Research of the 
International Association for the Study of Pain and the directive of the European Economic 
Community (86/609/ECC). The experiments were approved by the Committee of Animal 
Research at the University of Szeged (I-74-12/2012) and the Scientific Ethics Committee for 
Animal Research of the Protection of Animals Advisory Board (XXIV/352/2012). Male 
Sprague-Dawley rats were housed under standard laboratory conditions, on a 12-h light-dark 
cycle, with tap water and rat chow available ad libitum. The suffering of the animals and the 
number of animals used were kept at a minimum. 
 
Mild stimulation procedure 
Twenty-four animals (250-300 g) were used. Half of the animals received an intravenous 
(i.v.) injection of 50 mg/kg BBG, while the other half were injected with the vehicle of BBG, 
physiological saline. Two h after the BBG or saline injection, the animals were deeply 
anesthetized with chloral hydrate (400 mg/kg) and the head was secured in a stereotaxic 
apparatus (Stoelting Co., Wood Dale, USA). A hole, approximately 3 mm in diameter, was 
drilled into the right side of the skull with a dental drill, and a concentric bipolar electrode 
(FHC Inc., Bowdoin, USA, CBBRE75) was lowered to the right trigeminal ganglion. Half of 
the animals from the saline-treated group (5SStim) and half of the animals from the BBG 
group (5BStim) were electrically stimulated for 5 min with 5 Hz, 0.5 mA, 0.5 ms delay twin 
pulses generated by an Electrostimulator ST3 (Medicor Hungary). The other animals from 
both groups were used as sham animals: the electrode was lowered to the right trigeminal 
ganglion for 5 min, but no stimulation was performed (5SSham and 5BSham groups). After 
both procedures, the animals were returned to their home cages and maintained under deep 
anaesthesia covered by a warming blanket for 2 h. 
 
Robust stimulation procedure 
 
Twenty-one animals (250-300 g) were used; the treatment and surgical procedures were 
identical to the previous ones, except that the stimulation parameters of 10 Hz, 0.5 mA, 
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0.5 ms delay twin pulses were applied for 30 min, and the animals were maintained under 
deep anaesthesia, covered by a warming blanket, in their home cages for 4 h from the 
beginning of the stimulation. In both the mild and the robust paradigm, the jaw of the animal 
was twitching during the electrical stimulation, indicating the correct placement of the 
electrode. 
Overview of the robust stimulation groups: 
Saline + 30-min sham: 30SSham (n=6) 
Saline + 30-min stimulation: 30SStim (n=5) 
BBG + 30-min sham: 30BSham (n=4) 
BBG + 30-min stimulation: 30BStim (n=6) 
 
Orofacial formalin test 
Behavioural tests 
Rats (n=52, 200-240 g) were injected i.v. either with 50 mg/kg BBG or with physiological 
saline. One hour and fifty minutes later, the animals were placed in a 30x30x30 cm box, with 
mirrored walls for the monitoring of behavioural activity. After 10 min of habituation, the 
animals were taken out of the box and under minimal restraint were injected subcutaneously 
with 50 µL of either physiological saline (SSal and BSal groups) or 1.5% formalin (SForm 
and BForm groups) to the right whisker pad. After the injection, they were returned 
immediately to the box and their behaviour was monitored for 45 min under video 
surveillance. The injection of formalin causes a behavioural response, which consists in 
rubbing and scratching of the injected whisker pad with the ipsilateral fore- or hindpaw. The 
rate of this behaviour correlates with the pain sensation caused by formalin (Clavelou et al. 
1989). The 45-min period was divided into 15x3-min blocks, and the total time spent rubbing 
the injected whisker pad, measured in seconds, was taken as the nociceptive score in the given 
block. The normal grooming activity of the saline-treated animals was measured as control. 
After the monitoring period, the animals were returned into their home cages and maintained 
under standard laboratory conditions until perfusion, which was performed under deep chloral 
hydrate anaesthesia 4 h after the whisker pad injections. 
 
Immunohistochemistry  
Animals were perfused with 0.1 M phosphate-buffered saline (PBS), followed by 4% 
paraformaldehyde in 0.1 M phosphate buffer. The whole brain and the upper cervical spinal 
cord were removed and postfixed overnight in the same fixative. The correct placement of the 
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electrode was checked during autopsy, the electrode was in the ganglion in all cases. 
Cryoprotection was performed, using gradient sucrose solutions up to 30%. Sections from the 
TNC were prepared from the block, ranging from 1 mm rostral to 4 mm caudal from the obex, 
and the ventral part of the control (left) side of the blocks was marked by a small incision to 
enable side discrimination on the sections. 30 µm thick transverse sections were cut and 
serially collected in 18 wells containing PBS with 0.1% sodium azide, the overall distance 
therefore being 540 µm between consecutive sections. Free-floating sections were immersed 
in 0.3% H2O2 in PBS to block endogenous peroxidase activity. After several washes in PBS 
containing 1% Triton X-100 (PBS-T), they were incubated for 1 h in PBS-T containing 10% 
normal goat serum. The sections were then incubated overnight at room temperature in the 
primary antibody for c-Fos (1:2000, Santa Cruz Biotechnology, sc-52) or CGRP (1:20000, 
Sigma-Aldrich C8198). The immunohistochemical reaction was visualized by using the 
Vectastain Elite avidin-biotin kit (PK6101; Vector Laboratories,) with 3,3’-diaminobenzidine 
as chromogen (Sigma-Aldrich) intensified with nickel ammonium sulfate (Scharlau Chemie). 
The specificity of the immune reactions was verified by omitting the primary antisera. 
Sections were mounted onto glass slides, air-dried and coverslipped with DPX mounting 
medium (Scharlau Chemie). On the basis of anatomical observations, sections from the same 
rostro-caudal level were compared during the statistical evaluation.  
An observer blinded to the treatment procedures used a Nikon Optiphot-2 light microscope 
under a 20x objective to count cells immunopositive for c-Fos. The whole area of the laminae 
I-II in each section of the TNC was evaluated and counted . 
CGRP-stained sections were photographed with a Zeiss AxioCam MRc Rev.3 digital camera 
attached to a Zeiss AxioImager M2 microscope. Digital images were taken with a 20x 
objective in TNC laminae I-II, and the area covered by CGRP-immunoreactive fibres was 
measured through the use of ImageProPlus 6.2 software (Media Cybernetics Inc.) by an 
observer blinded to the treatment procedures.  
 
Statistical analysis 
The cell count results were aligned according to the rostro-caudal location of the section as 
mentioned above. Data from different levels of the TNC were handled separately, and 
analysed by two-way repeated measures ANOVA. The group were used as the between-
subject factor and the levels (-13.89, -14.43, -14.97, -15.51, -16.05, -16.59, -17.13, -17.67, -
18.21 mm from bregma) as the within-subject factor for the analysis. 
9 
When Mauchly’s test of sphericity proved to be significant, the Greenhouse-Geisser 
correction was performed. Pairwise comparisons of group means were performed on the basis 
of estimated marginal means with Sidak adjustment for multiple comparisons. 
The sums of the areas covered by CGRP-immunoreactive fibres were compared between 
groups according to the different levels, two-way repeated measures ANOVA being used as 
detailed above. 
Nociceptive scores from the behavioural study were compared block by block through 
two-way repeated measures ANOVA. Groups were used as between-subject factor and blocks 
(1-15) as within-subject factor for the analysis. Other statistical parameters were identical to 
those mentioned above. 
Statistical analyses were carried out with IBM SPSS Statistics, version 20 (IBM Corporation) 
software. All tests were two-sided, and p<0.05 was considered to be statistically significant. 
Graphs were prepared by using SigmaPlot 12.0 (Systat Software Inc.). Data are reported as 
means ± SEM. 
10 
Results 
 
Mild stimulation procedure 
As a significant interaction was found between the two investigated factors (levels and 
groups, p<0.01) for the number of c-Fos-immunoreactive cells in the mild stimulation 
paradigm, both effects could not be reported independently, whereas the group differences 
could be examined separately across different levels on the basis of the estimated marginal 
means for multiple comparisons. 
Lowering of the electrode to the trigeminal ganglion for 5 min without stimulation (5SSham 
group) did not cause any significant change in the number of c-Fos-immunoreactive cells in 
the TNC relative to the control side. The comparisons of the cell numbers from the control 
(left) sides for each of the four treatment groups did not reveal any significant changes (data 
not shown), and therefore only the data for the stimulated (right) sides of the groups are 
presented in Fig. 1. a-d. Electrical stimulation of the ganglion caused a significant increase in 
the number of c-Fos-immunoreactive (IR) cells along the whole extent of the examined region 
of the TNC (Fig. 1a,b,e). BBG exhibited a significant effect (p<0.01) compared with the 
saline treated stimulated animals only at the level of -13.89 mm from bregma (Fig. 1b,c,e).  
A significant interaction was found between the groups and levels, when the area values from 
the CGRP measurements were examined. However, the comparisons of the groups and 
stimulated-control sides at different levels did not reveal any significant alteration (Fig. 2).  
 
Robust stimulation procedure 
A significant interaction was not found between the investigated factors of levels and groups 
for the number of c-Fos-immunoreactive cells in the robust stimulation paradigm. The levels 
had a significant effect (p<0.001), and there was also a significant difference between the 
groups (p<0.001). Pairwise comparisons revealed that there was no significant difference 
between the control sides of the four treatment groups (data not shown). Lowering of the 
electrode without stimulation did not cause significant changes in the number of c-Fos IR 
cells in either sham-treated group as compared with the control (Fig 3e, 30SSham and 
30BSham with the 30SStim control side). Robust stimulation caused a marked increase in the 
number of c-Fos IR cells in the saline-treated animals (Fig. 3a,b,e, 30SStim compared with 
30SSham, #p <0.001). BBG had a significant attenuating effect on this increase (Fig. 3b,d,e, 
30SStim compared with 30BStim).  
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CGRP expression was not altered by stimulation or BBG administration in any of the animal 
groups (Fig. 4). 
 
Orofacial formalin test 
A significant interaction was found between time and groups (p<0.05) during the analysis of 
the behavioural data from the orofacial formalin test. The pairwise comparison revealed that 
the nociceptive scores of the saline-injected groups (SSal and BSal) did not differ from each 
other at any time point (Fig. 5). The injection of formalin caused a significant increase in the 
nociceptive scores in blocks 1 and 5-7 (Fig. 5, SForm compared with SSal). After the 
injection of formalin into the whisker pad, the BBG-treated animals demonstrated 
significantly increased nociceptive scores in blocks 1, 6 and 8 as compared with the control 
(Fig. 5, $p<0.05). The BBG-treated animals spent less time rubbing their formalin-injected 
side in both blocks 1 and 5-7, but this difference was not significant compared with the SForm 
group. In block 8, BBG treated animals spent significantly more time rubbing their whisker 
pad as did the animals in the formalin group (Fig. 5). In our experiments, the second phase of 
the formalin test subsided more quickly as expected in the SForm group, while it was more 
prolonged in the BForm group, and this difference may account for the significant effect of 
BBG in block 8. 
A significant interaction was observed between the levels and groups (p<0.001) for the 
number of c-Fos IR cells in the orofacial formalin test. There was no significant difference 
when either the control (left) sides or the control and saline-injected sides were compared at 
any level (Fig. 6e). The injection of formalin increased the number of c-Fos-IR cells 
significantly at the levels -16.59 mm to -15.51 mm, mainly in the central part of the TNC as 
compared with the saline-injected side in the SSal group. In the BForm group, a similar 
pattern was observed, except that the difference involved one additional level (-14.97 mm, 
Fig. 6e). There was no significant difference between the SForm and BForm groups at any 
level (Fig. 6b,d). 
No group difference was found in any of the measured parameters as regards the CGRP 
immunoreactivity (Fig. 7). 
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Discussion 
Numerous stimulation parameters and stimulation times have been applied in previous 
experiments, and we therefore decided to make use of two stimulation procedures, a short, 
mild stimulation and a longer, robust stimulation, in order to examine the possible effects of 
P2X7-R antagonism on trigeminal activation. As P2X7-R blockade was previously found to 
be effective in inflammatory conditions, we additionally examined the effects of BBG in a 
model of orofacial inflammation, the orofacial formalin test. 
Mild, short electrical stimulation of the trigeminal ganglion has been reported to lead to 
activation of the trigeminal system (Takemura et al. 2000), and this was supported by our 
results. The activation may be direct, stemming from depolarization of the central terminals of 
the primary trigeminal afferents, or it may be indirect, resulting from the release of peripheral 
mediators (histamine, bradykinin, substance P or CGRP). 
We observed a similar pattern in the robust stimulation paradigm, the number of c-Fos IR 
cells increasing profoundly, indicating the activation of the trigeminal system. 
The main difference seen between the two paradigms was in the number of cells activated 
after stimulation. Following the robust stimulation procedure more c-Fos IR cells were found 
in the TNC, suggesting a higher degree of activation than in the mild stimulation procedure. 
This higher degree of activation may be attributed to the higher frequency applied in the 
robust paradigm, which can lead to the more rapid firing of the primary trigeminal neurons. 
An increased firing rate may cause increased levels of transmitter release at both central and 
peripheral terminals, resulting in a higher degree of activation at the TNC level (Samsam et al. 
1999). It is also plausible that the longer stimulation interval leads to more primary trigeminal 
cells being activated in the TG, and hence in the TNC. We assume that in our experimental 
setting both the increased frequency and the increased stimulation interval contributed to the 
higher activation level in the TNC.  
Pre-treatment with the P2X7-R antagonist BBG was effective only in the robust stimulation 
paradigm, resulting in a decrease of the activity, reflected by the c-Fos expression. P2X7-Rs 
can be found in the trigeminal system, both in the ganglion (Teixeira et al. 2010) and in the 
TNC (D'Amico et al. 2010), therefore BBG may modulate peripheral and central processes. 
BBG could modulate the nociceptive processing by interfering with the peripheral neurogenic 
inflammation, or by modulating non-synaptic communication within the ganglion (Matsuka et 
al. 2001). At the central level, BBG could affect P2X7-Rs on central presynaptic terminals 
and modulate glutamate release (D'Amico et al. 2010), and thereby influence nociceptive 
transmission. Presumably, after the robust stimulation, where the more pronounced peripheral 
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activation and more severe inflammation also involve P2X7-Rs, the blocking effect of BBG 
manifests, while in the mild paradigm due to the minor changes the effect of BBG does not 
emerge.  
Neither the mild nor the robust stimulation procedure caused alterations in the levels of 
CGRP. It was earlier found that electrical stimulation of the trigeminal ganglion with 
parameters similar to our robust stimulation, led to the depletion of CGRP from the medial 
one-third of the central terminals of the trigeminal afferents (Knyihar-Csillik et al. 1998). 
However, those examinations were conducted immediately after stimulation of the trigeminal 
ganglion, whereas in our experiments a 2 or a 4 h survival time was included for better 
observability of the activity changes (c-Fos). These periods might be sufficient for the 
depleted CGRP to be resynthesized and for the changes in CGRP-immunoreactivity seen 
immediately after stimulation to normalize. BBG treatment did not modify the levels of 
CGRP in either the sham or the stimulated group. 
The injection of formalin into the whisker pad causes a biphasic behavioural effect (Clavelou 
et al. 1989), as also seen in our experiments. The first short and intense phase is thought to be 
caused by the immediate activation of the Aδ and C fibres and may be referred as acute pain. 
The second phase is less intense, but prolonged, and probably caused by sensitization of the 
trigeminal system due to the inflammatory processes occurring at the periphery. BBG did not 
exhibit any effect in the first phase of the formalin response. When formalin was applied to 
the hind paw and was combined with a selective P2X7-R antagonist, A-438079, in previous 
work, protective effect was exerted only in the second phase of the formalin test 
(McGaraughty et al. 2007). Furthermore, BBG was earlier shown to be hyperalgesic in the 
modulation of acute nociception in the hot-plate test (Ando et al. 2010). These results suggest 
that BBG and blockade of the P2X7-Rs may not be effective against acute nociception. 
In the second phase of the formalin test, BBG did not demonstrate any obvious effect. At the 
beginning of the second phase (in blocks 5-7), the nociceptive scores revealed a decreasing 
tendency, while in the later blocks the opposite could be observed. Since another P2X7-R 
antagonist was effective when formalin was applied at the hind paws, our results suggest that 
the role of the P2X7-Rs in the sensory system is not uniform.  
Four h after formalin injection, c-Fos immunohistochemistry revealed that the TNC displays 
clear activation. The pattern of activation corresponds to the somatotopic projection pattern of 
the injected area. BBG had no effect on the activation of the trigeminal system after formalin. 
Our results in the orofacial formalin test are somewhat surprising, considering that other 
antagonists of the P2X7-Rs (Borsani et al. 2010; Honore et al. 2006; McGaraughty et al. 
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2007) and even BBG (Ando et al. 2010) have proven effective in numerous inflammatory 
models. However, none of these experiments related to the trigeminal system, and our results 
are the first regarding the effects of blockade of the P2X7-Rs by BBG in this area after 
inflammation caused by formalin. 
The levels of CGRP were not altered 4 h after formalin injection, and following treatment 
with BBG. Alterations in CGRP usually occur immediately during or after the applied 
stimulus and cease within a matter of hours (Buzzi et al. 1991; Greco et al. 2008), and our 
results agree with this. However, in the nitroglycerin model, changes in CGRP 
immunoreactivity were seen 4 h after nitroglycerin administration, suggesting that the 
alterations in CGRP levels can be long-term. The effect of P2X7-R antagonism on the 
expression of CGRP in the formalin test should be further elucidated with regard to the time 
scale. 
BBG in the micromolar range was previously shown to inhibit voltage-dependent sodium 
channels in vitro (Jo and Bean 2011), and it might therefore be possible that this feature of 
BBG contributes to its effects in our experiments. This is rather unlikely, considering that we 
applied BBG in a single dose, which has been shown not to reach micromolar levels even 
after continuous administration in mice (Diaz-Hernandez et al. 2012). 
In conclusion, our results suggest that P2X7-Rs have a role in the modulation of trigeminal 
nociceptive processing. Further investigations of the relations of the trigeminal system and 
P2X7-R signalling may provide important details concerning trigeminal nociceptive 
processing and the pathomechanism of headaches. 
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Figure captions  
 
Fig. 1 Summary of the results from the mild stimulation paradigm regarding c-Fos 
immunostaining. Representative photos from the right sides of the four treatment groups after 
c-Fos immunohistochemistry, taken at 16.05 mm caudally from bregma: a 5SSham, b 
5SStim, c 5BSham, d 5BStim. Scale bar 200 µm. Diagram showing the number of c-Fos-
immunoreactive cells across the different levels of the TNC after mild electrical stimulation of 
the trigeminal ganglion (group means ± SEM) e. There was no significant difference between 
the control (left) sides (data not shown). For clarity, only the control side of the saline-treated 
stimulated group is presented. The hashmarks indicate significance in the comparison of the 
right sides of the 5SSham and 5SStim groups at different levels of the TNC (#p<0.05; 
##p<0.01; ###p<0.001). BBG treatment showed an attenuating tendency, though it proved to be 
significant merely at the level of -13.89 mm (**p<0.01, 5SStim – 5BStim) 
 
Fig. 2 Diagram showing the area covered by CGRP-immunoreactive fibres at the different 
levels of the TNC in the different treatment groups after mild electrical stimulation of the 
trigeminal ganglion (group means ± SEM). There was no significant difference between either 
the control or the stimulated sides or the different groups. For clarity, only the control side of 
the saline-treated stimulated group is presented 
 
Fig. 3 Summary of the results from the robust stimulation paradigm regarding c-Fos 
immunostaining. Representative photos from the right sides of the four treatment groups after 
c-Fos immunohistochemistry, taken at 16.05 mm caudally from bregma: a 30SSham, b 
30SStim, c 30BSham, d 30BStim. Scale bar 200 µm. Diagram showing the number of c-Fos-
immunoreactive cells at different levels along the rostro-caudal axis in the TNC (group means 
± SEM) in the robust stimulation paradigm e. There was no significant difference between the 
control sides (data not shown). For clarity, only the control side of the saline-treated 
stimulated group is presented. Electrical stimulation of the right trigeminal ganglion caused a 
significant increase in the number of c-Fos-positive cells as compared with the right side of 
the sham group at all levels examined (###p<0.001 30SSham – 30SStim). BBG treatment had 
a significant decreasing effect on the cell counts (*** p<0.001 30SStim – 30BStim) 
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Fig. 4 Diagram showing the area covered by CGRP-immunoreactive fibres at the different 
levels of the TNC in the different treatment groups after robust electrical stimulation of the 
trigeminal ganglion (group means ± SEM). There was no significant difference between either 
the control or the stimulated sides or the different groups. For clarity, only the control side of 
the saline-treated stimulated group is presented 
 
Fig. 5 Diagram showing the mean nociceptive scores in different time blocks from the four 
treatment groups (group means ± SEM, n=13) in the orofacial formalin test. The injection of 
formalin increased the nociceptive score in blocks 1 and 5-7 as compared with the 
saline-injected animals (#p<0.05, ##p<0.01). BBG treatment did not affect the nociceptive 
scores after saline injection, and did not modify the normal behaviour. The nociceptive scores 
of the BBG and saline-treated formalin-injected groups did not differ significantly in any 
block 
 
Fig. 6 Summary of the results from the orofacial formalin test regarding c-Fos 
immunostaining. Representative photos from the right (injected) sides of the four treatment 
groups after c-Fos immunohistochemistry taken at 16.05 mm caudally from bregma: a SSal, b 
SForm, c BSal, d BForm. Scale bar 200 µm. Diagram showing the mean number of c-Fos 
immunoreactive cells along the rostro-caudal axis in the TNC in the orofacial formalin test 
(group means ± SEM) e. Injection of saline did not cause any increase in the number of c-Fos-
positive cells (SSal and BSal groups). The effect of formalin was visible only on the injected 
side; the control sides were similar to those in the saline-injected controls. For clarity, only the 
control side of the SForm animals is presented. Formalin caused an increase in c-Fos cell 
number on the ipsilateral side as compared with the saline-injected side of the controls 
(SForm compared with SSal), significant at the levels -16.59 to -15.51 mm (###p<0.001). In 
the BBG-treated rats, formalin had a similar activity-increasing effect, significant at the levels 
-16.59 to -14.97 mm ($p<0.05; $$p<0.01; $$$p<0.001). The groups SForm and BForm did not 
differ significantly from each other  
 
Fig. 7 Summary of the results after CGRP immunostaining in the orofacial formalin test. 
Representative photos of CGRP immunohistochemistry on the right sides of the TNC from 
the four treatment groups taken at 14.97 mm caudally from bregma a 5SSham, b 5SStim, c 
5BSham, d 5BStim. Scale bar 200 µm. 
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Diagram showing the area covered by CGRP-immunoreactive fibres at the different levels of 
the TNC in the different treatment groups in the orofacial formalin test (group means ± 
SEM) e. There was no significant difference between either the control or injected sides or the 
different groups. For clarity, only the control side of the saline-treated formalin-injected group 
is presented 
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